Inside the research
Tandem Diabetes Care, Inc.
TNDM Research profile · latest available data
Price overview
$15.72
▲ +0.50 (+3.3%)
| 52w hi | $28.26 |
|---|---|
| 52w lo | $11.79 |
| Vol | 2.84M |
| As of | 25 Sep 2026 |
The Verdict
Our score -0.11
| Short | +0.33 |
|---|---|
| Medium | -0.17 |
| Long | -0.86 |
computed 2026-09-27
Key fundamentals
Tandem Diabetes Care, Inc.
Healthcare · Medical Devices
| Market cap | $1.09B |
|---|---|
| Enterprise value | $1.38B |
| Forward P/E | 93.74x |
| EV / EBITDA | -55.01x |
| P / S (ttm) | 1.05x |
| Profit margin | -6.1% |
| Return on equity | -48.0% |
| Revenue growth | +5.8% |
| Debt / equity | 566.96 |
Layer Breakdown
| Layer | Raw | Contribution |
|---|---|---|
| Fundamental | -0.19 | |
| Sector | +0.08 | |
| Technical | -0.15 | |
| Earnings | +0.00 | |
| Sentiment | +0.51 |
macro × 1.00 · 2026-09-27
Business overview
Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. It's flagship products are the t:slim X2 insulin delivery system; and Tandem Mobi insulin pump, an automated insulin delivery system. The company also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, it offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. The company has collaboration agreement with the University of Virginia Center for Diabetes Technology for research and development of fully automated closed-loop insulin delivery systems. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.
Risk Metrics
| Beta vs SPX | 1.17 |
|---|---|
| Corr SPX | 0.25 |
| Annual vol | 74.2% |
| Annual ret | -24.3% |
| Sharpe | -0.33 |
| Max DD | -77.7% |
Window: 504 trading days (504 obs)
Material Events
| Date | Event | 8-K |
|---|---|---|
| 2026-08-06 | Earnings Release, Exhibits | read |
| 2026-05-21 | 3.03, Officer / Director Change… | read |
| 2026-05-15 | Officer / Director Change | read |
| 2026-05-07 | Earnings Release, Exhibits | read |
| 2026-02-27 | Material Agreement, Material Obligation… | read |
| 2026-02-19 | Earnings Release, Exhibits | read |
| 2025-12-30 | Bylaws Amendment, Exhibits | read |
| 2025-11-12 | Officer / Director Change, Exhibits | read |
| 2025-11-06 | Earnings Release, Exhibits | read |
| 2025-08-07 | Other Material Event | read |
| 2025-08-06 | Earnings Release, Exhibits | read |
| 2025-05-23 | Material Agreement, Shareholder Vote | read |
Insider Trades
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-15 | Kyrillos Jean-Claude | EVP & Chief Operating Off | Option exercise | 3.64K | — |
| 2026-07-15 | Kyrillos Jean-Claude | EVP & Chief Operating Off | Withheld for tax | 1.93K | $29.43K |
| 2026-06-02 | Gasser Elizabeth Anne | EVP, Chief Strategy Offic | Gift | 7.16K | — |
| 2026-05-21 | Allen Dick | Option exercise | 8.76K | — |
Flow & Concentration
| Insider 180d net | $0 |
|---|---|
| Insider buys / sells | 0 / 0 |
| Insider bias | Neutral |
| 13F holders | 7 |
| Top-5 share | 98.2% |
| HHI | 3,119 (concentrated) |
Top Holders
| Holder | Value | Shares |
|---|---|---|
| Capital Research / Capital World | $95.45M | 6.33M |
| State Street Corp | $43.03M | 2.85M |
| Citadel Advisors | $27.98M | 1.85M |
| Millennium Management | $19.79M | 1.31M |
| AQR Capital Management | $8.06M | 533.84K |
| Fidelity / FMR LLC | $3.58M | 3.79M |
| T. Rowe Price Group | $1.33K | 88.32K |
As of 2026-06-30
SEC Filings
The Long Run
FY 2014–2025 · 12 years
| Line | Latest | CAGR | Trend |
|---|---|---|---|
| Revenue | $940.20M | +59.7% | |
| Gross profit | $367.69M | +85.7% | |
| Operating income | -$187.26M | +0.0% | |
| Net income | -$204.71M | — | |
| Cash from ops | -$31.81M | +6.4% |
Indices
Recent Sessions
| Date | Open | High | Low | Close | Vol |
|---|---|---|---|---|---|
| Sep 25 | $15.20 | $16.18 | $14.83 | $15.72 | 2.84M |
| Sep 24 | $16.43 | $16.60 | $15.20 | $15.22 | 2.65M |
| Sep 23 | $17.44 | $17.67 | $15.86 | $16.38 | 2.81M |
| Sep 22 | $17.88 | $18.03 | $16.97 | $17.50 | 2.69M |
| Sep 21 | $17.01 | $17.83 | $16.60 | $17.62 | 2.10M |
Understand the score. Research layers are inputs to a model, and the available data has limits.
Read the methodology →